In late April 2026, CONMED Corporation reported first-quarter sales of US$317.05 million, higher net income of US$13.83 million, and raised its 2026 revenue guidance to US$1.35–US$1.38 billion while ...

How CONMED Stock Has Been Trading Recently CONMED (CNMD) has drawn attention after a mixed stretch in the share price, with a slight gain over the past month alongside declines over the past 3 months ...

Q1 2026 Management View "During the first quarter, we reached an agreement to divest certain GI products. And in April, we reached a second agreement to divest our remaining GI products." (President, ...

Conmed Corporation’s latest earnings call struck a tone of cautious optimism, as management balanced softer near‑term metrics with clear signs of strategic and operational progress. While reported ...

We think that DENTSPLY stock (NASDAQ NDAQ: XRAY), a dental equipment company, is currently a better pick than ConMed (NASDAQ: CNMD), a medical devices company that specializes in products for ...

CONMED Corporation reshapes its healthcare strategy with strong earnings, refined focus, and evolving market sentiment within ...

NEW YORK (Reuters) - Activist investor Voce Capital Management LLC is pushing ConMed Corp (NSQ:CNMD) to pursue a sale, saying it believes the surgical-device maker could attract buyout interest from ...

We think that Stryker Corporation currently is a better bet compared to Conmed Corp. CNMD stock trades at 4x trailing revenues, lower than that of SYK, whose P/S multiple stands at 6.1x. Does this gap ...

CONMED stock draws attention as healthcare technology trends evolve, highlighting company developments, institutional activity, and sector positioning within the broader medical device landscape ...

CONMED Corporation CNMD is well poised for growth in the coming quarters, courtesy of its broad product spectrum. The optimism, led by the solid recurring revenue base and potential in General Surgery ...